8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Dexcom Promotes CFO Jereme Sylvain to Chief Operating Officer
Filed with the SEC on · Summarized by InvestorsBot
Dexcom appointed Executive Vice President and Chief Financial Officer Jereme Sylvain as Chief Operating Officer effective September 14, 2026, adding oversight of global operations and quality teams to his responsibilities. Under his September 11 offer letter, Sylvain will receive an annual base salary of $767,000 and a target bonus opportunity equal to 75% of base salary, while remaining eligible for equity awards and executive benefits.